Kaneda Y - Search Results

1

[Gene therapy for attenuating chronic rejection of cardiac allografts].

Suzuki J, Isobe M, Morishita R, Kaneda Y, Kawauchi M, Amano J. Suzuki J, et al. Among authors: kaneda y. Nihon Rinsho Meneki Gakkai Kaishi. 1999 Dec;22(6):418-21. doi: 10.2177/jsci.22.418. Nihon Rinsho Meneki Gakkai Kaishi. 1999. PMID: 10726477 Review. Japanese. No abstract available.

2

Downregulation of endothelin expression in allograft coronary arteries after gene therapy targeting Cdk2 kinase.

Isobe M, Suzuki J, Morishita R, Kaneda Y, Sawa Y, Matsuda H, Ogihara T, Horie S, Okubo Y, Amano J. Isobe M, et al. Among authors: kaneda y. Transplant Proc. 1998 Jun;30(4):1007-8. doi: 10.1016/s0041-1345(98)00129-8. Transplant Proc. 1998. PMID: 9636407 No abstract available.

3

Antisense Bcl-x oligonucleotide induces apoptosis and prevents arterial neointimal formation in murine cardiac allografts.

Suzuki J, Isobe M, Morishita R, Nishikawa T, Amano J, Kaneda Y. Suzuki J, et al. Among authors: kaneda y. Cardiovasc Res. 2000 Feb;45(3):783-7. doi: 10.1016/s0008-6363(99)00356-9. Cardiovasc Res. 2000. PMID: 10728401

4

Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts.

Suzuki J, Morishita R, Amano J, Kaneda Y, Isobe M. Suzuki J, et al. Among authors: kaneda y. Gene Ther. 2000 Nov;7(21):1847-52. doi: 10.1038/sj.gt.3301316. Gene Ther. 2000. PMID: 11110417

5

Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide.

Suzuki J, Isobe M, Morishita R, Aoki M, Horie S, Okubo Y, Kaneda Y, Sawa Y, Matsuda H, Ogihara T, Sekiguchi M. Suzuki J, et al. Among authors: kaneda y. Nat Med. 1997 Aug;3(8):900-3. doi: 10.1038/nm0897-900. Nat Med. 1997. PMID: 9256282

6

Antisense Cdk2 kinase oligodeoxynucleotide inhibits ICAM-1 expression in murine cardiac allograft arteriopathy.

Suzuki J, Isobe M, Morishita R, Aoki M, Yamazaki S, Kaneda Y, Sawa Y, Matsuda H, Ogihara T, Horie S, Okubo Y, Sekiguchi M. Suzuki J, et al. Among authors: kaneda y. Transplant Proc. 1998 Feb;30(1):89-90. doi: 10.1016/s0041-1345(97)01188-3. Transplant Proc. 1998. PMID: 9474966 No abstract available.

7

Prevention of cardiac allograft arteriopathy by antisense Cdc2 kinase oligonucleotide.

Suzuki J, Izawa A, Morishita R, Kaneda Y, Sawa Y, Okubo Y, Ogihara T, Sekiguchi M, Isobe M. Suzuki J, et al. Among authors: kaneda y. Transplant Proc. 1999 Feb-Mar;31(1-2):867-8. doi: 10.1016/s0041-1345(98)01808-9. Transplant Proc. 1999. PMID: 10083378 No abstract available.

8

Antisense Cdc2 kinase oligonucleotide inhibits adhesion molecule expression in cardiac allograft arteriopathy.

Suzuki J, Izawa A, Morishita R, Kaneda Y, Sawa Y, Okubo Y, Ogihara T, Sekiguchi M, Isobe M. Suzuki J, et al. Among authors: kaneda y. Transplant Proc. 1999 Feb-Mar;31(1-2):955-6. doi: 10.1016/s0041-1345(98)01853-3. Transplant Proc. 1999. PMID: 10083423 No abstract available.

9

E2F decoy suppresses E-selectin expression in murine cardiac allograft arteriopathy.

Suzuki J, Isobe M, Morishita R, Izawa A, Yamazaki S, Okubo Y, Kaneda Y, Sekiguchi M. Suzuki J, et al. Among authors: kaneda y. Transplant Proc. 1999 Aug;31(5):2018-9. doi: 10.1016/s0041-1345(99)00253-5. Transplant Proc. 1999. PMID: 10455960 No abstract available.

10

Gene therapy for heart transplantation-associated coronary arteriosclerosis.

Isobe M, Suzuki J, Morishita R, Kaneda Y, Amano J. Isobe M, et al. Among authors: kaneda y. Ann N Y Acad Sci. 2000 May;902:77-83. doi: 10.1111/j.1749-6632.2000.tb06302.x. Ann N Y Acad Sci. 2000. PMID: 10865827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,110 results

Search Page

Filters